Characterization of signaling pathways leading to Fas expression induced by TNF-alpha: pivotal role of NF-kappaB

FASEB J. 2005 Mar;19(3):473-5. doi: 10.1096/fj.04-2726fje. Epub 2004 Dec 15.

Abstract

TNF-alpha is known to induce a strong up-regulation of Fas expression in mouse Sertoli cell cultures, leading to their apoptosis triggered by effector FasL-bearing cells. These data suggest that increased Fas expression on the cell surface might be a key event in the pathogenesis of autoimmune orchitis, by inducing a leakage of the blood-tubular barrier as a consequence of Sertoli cell apoptosis. In the present paper, we have investigated the signal transduction mechanisms involved in the regulation of Fas expression induced by TNF-alpha in mouse Sertoli cells. We studied the role of the transcription factor NF-kappaB and of MAPKs in regulating Fas expression. By using Sertoli cells transfected with a NF-kappaB Luc reporter gene, we proved that TNF-alpha activates the IkappaB/NF-kappaB system. Moreover, the use of the proteasome inhibitor lactacystin led us to demonstrate that NF-kappaB is required for TNF-alpha mediated Fas expression. By using specific inhibitors for each MAPK, we confirmed the pivotal role of the IkappaB/NF-kappaB system by demonstrating that ERKs, p38, and JNK are not involved in Fas up-regulation by TNF-alpha. The comprehension of these pathways could be relevant to the knowledge of the pathogenesis of autoimmune disorders in immune privileged districts of the body.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / analogs & derivatives
  • Acetylcysteine / pharmacology
  • Animals
  • Apoptosis
  • Cells, Cultured
  • Cysteine Proteinase Inhibitors / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / antagonists & inhibitors
  • Gene Expression Regulation / drug effects*
  • I-kappa B Proteins / metabolism
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Luciferases / genetics
  • MAP Kinase Kinase 4
  • Male
  • Mice
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / physiology
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / genetics
  • NF-kappa B / physiology*
  • Recombinant Fusion Proteins
  • Sertoli Cells / metabolism
  • Signal Transduction*
  • Transfection
  • Tumor Necrosis Factor-alpha / pharmacology*
  • fas Receptor / genetics*
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • Cysteine Proteinase Inhibitors
  • Enzyme Inhibitors
  • I kappa B beta protein
  • I-kappa B Proteins
  • NF-kappa B
  • Nfkbia protein, mouse
  • Recombinant Fusion Proteins
  • Tumor Necrosis Factor-alpha
  • fas Receptor
  • lactacystin
  • NF-KappaB Inhibitor alpha
  • Luciferases
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 4
  • Mitogen-Activated Protein Kinase Kinases
  • Acetylcysteine